This process prompts the release of pro-inflammatory cytokines, including IL-6, IL-12, IFN-γ and TNF-α, to create a delayed type hypersensitivity-like microenvironment that regulates prolonged anti-tumor adaptive responses [59]. This evidence concerns the gene IL6 and neoplasm.